Charles Dadswell
General Counsel bij ILLUMINA, INC.
Vermogen: 3 M $ op 31-03-2024
Profiel
Momenteel is Charles E. Dadswell Secretaris, Senior VP & Compliance Officer bij Illumina, Inc. In zijn vorige loopbaan was de heer Dadswell General Counsel bij BioDelivery Sciences International, Inc., Vice President-US Intellectual Property bij GlaxoSmithKline, Inc., Principal bij Glaxo Wellcome, Inc. en VP & General Counsel-North & Latin America bij bioMerieux, Inc. Charles E. Dadswell behaalde zijn doctoraal aan de Ferris State University (Michigan), zijn doctoraal aan de Thomas M. Cooley Law School en zijn doctoraal aan de George Washington University Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ILLUMINA, INC.
0.01% | 05-03-2024 | 22 298 ( 0.01% ) | 3 M $ | 31-03-2024 |
Actieve functies van Charles Dadswell
| Bedrijven | Functie | Begin |
|---|---|---|
| ILLUMINA, INC. | General Counsel | 22-04-2013 |
Eerdere bekende functies van Charles Dadswell
| Bedrijven | Functie | Einde |
|---|---|---|
bioMérieux, Inc.
 bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | General Counsel | 01-04-2013 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | General Counsel | 01-01-2010 |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Opleiding van Charles Dadswell
| Ferris State University (Michigan) | Undergraduate Degree |
| The Thomas M. Cooley Law School | Graduate Degree |
| George Washington University Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
bioMérieux, Inc.
bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
